- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Shilpa Medicare gets WHO-Geneva nod for API, Tenofovir Disoproxil Fumarate for HIV, Hepatitis B
Karnataka: Shilpa Medicare Limited has recently announced the receipt of confirmation of WHO - GENEVA approval for API, Tenofovir Disoproxil Fumarate.The medication is used to treat chronic hepatitis B and to prevent and treat HIV / AIDS, under pre-qualification program.Read also: Shilpa Medicare secures DRDO nod for manufacturing anti-COVID drug 2DGShilpa Medicare Limited started...
Karnataka: Shilpa Medicare Limited has recently announced the receipt of confirmation of WHO - GENEVA approval for API, Tenofovir Disoproxil Fumarate.
The medication is used to treat chronic hepatitis B and to prevent and treat HIV / AIDS, under pre-qualification program.
Read also: Shilpa Medicare secures DRDO nod for manufacturing anti-COVID drug 2DG
Ruchika Sharma joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751